Stimulation of the developing immune system can prevent autoimmunity

Journal of Autoimmunity

Volumn 14, Issue 1, 2000, Pages 15-22

  Singh, Bhagirath ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Autoimmunity; Immunoregulation; Immunostimulation; Infection; Regulatory T cells; Vaccination

Indexed keywords

BCG VACCINE; CYTOKINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GAMMA INTERFERON; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INTERLEUKIN 12; INTERLEUKIN 4; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE; VACCINE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CROSS REACTION; CYTOKINE PRODUCTION; ENVIRONMENTAL FACTOR; HEREDITY; IMMUNIZATION; IMMUNOMODULATION; IMMUNOSTIMULATION; INFECTION; MOLECULAR MIMICRY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0033966763     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0349     Document Type: Article

References (85)

1. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 91:1997;661-677.
2. Metcalf D. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. Blood. 92:1998;345-348.
3. Vialettes B., Maraninchi D. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet. 342:1993;174.
4. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rey. 15:1994;516-542.
5. Delovitch T.L., Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity. 7:1997;727-738.
6. +T cell subsets are required for the transfer of diabetes in non obese diabetic (NOD) mice. J. Immunol. 140:1988;52-58.
7. +T cells in the pathogenesis of organ specific autoimmune diseases. Immunol. Today. 16:1995;35-38.
8. Chaturvedi P., Qin H.Y., Chou H., Singh B. Modulation of Insulin dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells. Crit. Rev. Immunol. 17:1997;519-528.
9. Chen Y., Inobe J., Marks R., Gonnella P., Kuchroo V.K., Weiner H.L. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature. 376:1995;177-180.
10. +T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature. 389:1997;737-742.
11. +T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1998;1212-1218.
12. Harrison L.C., Dempsey-Collier M., Kramer D.R., Takahashi K. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin- dependent diabetes. J. Exp. Med. 184:1996;2167-2174.
13. Sadelain M.W., Qin H.Y., Lauzon J., Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes. 39:1990;583-583.
14. Qin H.Y., Sadelain M.W., Hitchon C., Lauzon J., Singh B. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 150:1993;2072-2080.
15. Qin H.Y., Elliott J.F., Lakey J.R.T., Rajotte R.V., Singh B. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice are modulated by adjuvant immunotherapy. J. Autoimmun. 11:1998;591-601.
16. Elliott J.F., Qin H.Y., Bhatti S., Smith D.K., Singh R.K., Dillon T., Lauzon J., Singh B. Immunization with larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes. 43:1994;1494-1499.
17. Tian J., Clare-Salzler M., Herschenfeld A., Middleton B., Newman D., Mueller R., Arita S., Evans C., Atkinson M.A., Mullen Y., Sarvetnick N., Tobin A.J., Lehmann P.V., Kaufman D.L. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2:1996;1348-1353.
18. +T cells that suppress adoptive transfer of diabetes. J. Autoimmun. 7:1994;655-663.
19. French M.B., Allison J., Cram D.S., Thomas H.E., Dempsey-Collier M., Silva A., Georgiou H.M., Kay T.W., Harrison L.C., Lew A.M. Transgenic expression of mouse proinsulin II prevents diabetes in non-obese diabetic mice. Diabetes. 46:1997;34-39.
20. Clare-Salzler M.J., Brooks J., Chai A., Van Herle K., Anderson C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J. Clin. Invest. 90:1992;741-748.
21. Singh, B. Rider, B.J. Zechel, M.A. Chaturvedi, P. 1998, In vivo induction of dendritic cells downregulate autoimmunity by modulation of antigen presentation to T cells, 455, 460.
22. Bendelac A., Rivera M.N., Park S.H., Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:1997;535-562.
23. Wilson S.B., Kent S.C., Patton K.T., Orban T., Jackson R.A., Exley M., Porcelli S., Schatz D.A., Atkinson M.A., Balk S.P., Strominger J.L., Hafler D.A. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature. 391:1998;177-181.
24. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 26:1996;2989-2998.
25. Lehuen A., Lantz O., Beaudoin L., Laloux V., Carnaud C., Bendelac A., Bach J.F., Monteiro R.C. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188:1998;1831-1839.
26. Hutchings P.R., Cooke A. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmur. 3:1990;175-185.
27. Boitard C., Yasunami R., Dardenne M., Bach J.F. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169:1989;1669-1680.
28. Hartemann A.H., Richard M.F., Boitard C. Absence of significant Th2 response in diabetes-prone non-obese diabetic (NOD) mice. Clin. Exp. Immunol. 116:1999;225-230.
29. Atkinson M.A., Leiter E.H. The NOD mouse model of type I diabetes: as good as it gets? Nat. Med. 5:1999;601-604.
30. Singh B., Rabinovitch A. Influence of microbial agents on the development of autoimmune diabetes. Autoimmunity. 15:1993;209-213.
31. Singh B., Prange S., Jevnikar A. Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus. Sem. Immunol. 10:1998;79-86.
32. Leiter, E.H. 1990, The role of environmental factors in modulating insulin dependent diabetes, The Role of Microorganism in Non-infectious disease, R.R.P. de Vries, I.R. Cohen, J.J. van Rood, Springer Verlag, Berlin, 39, 55.
33. Fohlman J., Friman G. Is Juvenile Diabetes a viral disease? Ann. Med. 25:1993;569-574.
34. Maclaren N.K., Atkinson M.A. Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms. Mol. Med. Today. 3:1997;76-83.
35. Yoon J.-W. Role of viruses in the pathogenesis of IDDM. Ann. Med. 23:1991;437-445.
36. Dyrberg T., MacKay P., Michelsen B., Petersen J., Karlsen A., Bonnevie V. Virus and Diabetes Mellitus. Friedman H., Rose N.R, Bendinelli M. Microorganisms and Autoimmune diseases. 1996;105-127 Plenum Press, New York.
37. Pozzilli P., Signore A., Williams A.J., Beales P.E. NOD mouse colonies around the world - recent facts and figures. Immunol. Today. 14:1993;193-196.
38. Wicker L.S., Todd J.A., Peterson L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:1995;179-200.
39. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes. 43:1994;613-621.
40. Sadelain M.W.J., Qin H.Y., Samoski W., Parfrey N., Singh B., Rabinovitch A. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J. Autoimmun. 3:1990;671-680.
41. Hempel K., Freitag A., Freitag B., Endres B., Mai B., Liebaldt G. Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant. Int. Arch. Allergy Appl. Immunol. 76:1985;193-199.
42. Qin H.Y., Singh B. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease accleration with cyclophosphamide. J. Autoimmun. 10:1997;271-278.
43. Wang T., Singh B., Warnock G.L., Rajotte R.V. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes. 41:1992;114-117.
44. Lakey J.R., Singh B., Warnock G.L., Elliott J.F., Rajotte R.V. Long-term survival of syngeneic islet grafts in BCG-treated diabetic NOD mice can be reversed by cyclophosphamide. Transplantation. 59:1995;1751-1753.
45. Qin H.Y., Chaturvedi P., Singh B. Apoptosis of diabetogenic T cells by adjuvant immunotherapy prevents autoimmunity in diabetic NOD mice: Implications for islet transplantation. Diabetes. 48:1999;0921.
46. Shehaden N.N., LaRosa F., Lafferty K.J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:1993;291-300.
47. Rabinovitch A., Suarez-Pinzon W.L., Sorensen O., Bleackley R.C., Power R.F. IFN-γ gene expression in pancretic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154:1996;4874-4882.
48. Singh B., Zechel M.A., Chaturvedi P., Qin H.Y. Downregulation of Fas ligand (FasL, CD95L) expression on T cells: a Novel mechanism for preventing spontaneous and adoptive transfer in IDDM. Diabetes. 47:1998;0859.
49. Shehadeh N.N., Calcinaro F., Bradley B., Bruchlim I., Vardi P., Lafferty K.J. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet. 343:1994;706-707.
50. Pozzilli P. BCG vaccine in insulin-dependent diabetes mellitus. IMDIAB Group. Lancet. 349:1997;1520-1521.
51. Parent M.-E., Fritschi L., Siemiatycki J., Fritschi L., Colle E. Bacille Calmette-Guérin vaccination and incidence of IDDM in Montreal, Canada. Diabetes Care. 20:1997;767-772.
52. Elliott J.F., Marlin K.L., Couch R.M. Effect of Bacille Calmette-Guérin vaccination on C-peptide secretion in children newly diagnosed with IDDM. Diabetes Care. 21:1998;1691-1693.
53. Dahlquist G., Gothefors L. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia. 38:1995;873-874.
54. Allen H.F., Klingensmith G.J., Jensen P., Simoes E., Hayward A., Chase H.P. Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study. Diabetes Care. 22:1999;1703-1707.
55. Shehadeh N, Etzioni A, Cahana A, Teninboum G, Gorodetsky B, Barzilai D, Karnieli E. Repeated BCG vaccination is more effective than a single dose in preventing diabetes in non-obese diabetic (NOD) mice. Isr. J. Med. Sci. 33:1997;711-715.
56. Singh B., Elliott J.F. Can progression of IDDM be prevented in newly diagnosed patients by BCG immunotherapy. Diabetes Prev. Ther. 11:1997;12-13.
57. Gibbon C., Smith T., Egger P., Betts P., Phillips D. Early infection and subsequent insulin dependent diabetes. Arch. Dis. Child. 77:1997;384-385.
58. Classen D., Classen J. The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus. Infect. Dis. Clin. Pract. 6:1997;449-454.
59. Blom L., Nyström L., Dahlquist G. The Swedish childhood diabetes study: vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia. 34:1991;176-181.
60. Yoon J.-W. The role of viruses and environmental factors in the induction of diabetes. Curr. Top. Microbiol. Immunol. 164:1990;95-123.
61. Lindberg B., Ahlfors K., Carlsson A., Ericsson U., Landin-Olsson M., Lernmark A., Ludvigsson J., Sundkvist G., Ivarsson S. Previous Exposure to Measles, Mumps, and Rubellabut Not Vaccination During Adolescence Correlates to the Prevalence of Pancreatic and Thyroid Autoantibodies. Pediatrics. 104:1999;e12.
62. Kemp T., Pearce N., Fitzharris P., Crane J., Fergusson D., St George I. Is infant immunisation a risk factor for childhood asthma or allergy. Epidemiology. 8:1997;678-680.
63. Peltola H., Patja A., Leinikki P., Valle M., Davidkin I., Paunio M. No evidence for measles, mumps and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet. 351:1998;1327-1328.
64. Classen J.B., Classen D.C. Vaccines modulate IDDM. Diabetologia. 39:1996;500-502.
65. Jefferson T., Demicheli V. No evidence that vaccines cause insulin dependent diabetes mellitus. J. Epidemiol. Community Health. 52:1998;674-675.
66. Karvonen M., Cepaitis Z., Tuomilehto J. Association between type I diabetes and Haemophilus influenzae type b vaccination: birth cohort study. BMJ. 318:1999;1169-1172.
67. Juhela S., Hyoty H., Uibo R., Meriste S.H., Uibo O., Lonnrot M., Halminen M., Simell O., Ilonen J. Comparison of enterovirus-specific cellular immunity in two populations of young children vaccinated with inactivated or live poliovirus vaccines. Clin. Exp. Immunol. 117:1999;100-105.
68. Graves P.M., Barriga K.J., Norris J.M., Hoffman M.R., Yu L., Eisenbarth G.S., Rewers M. Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care. 22:1999;1694-1697.
69. Oldstone M. Molecular mimicry and autoimmune disease. Cell. 50:1987;819-820.
70. Tisch R., Yang X.-D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
71. Zechel M.A., Elliott J.F., Atkinson M.A., Singh B. Characterization of novel T cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice. J. Autoimmun. 11:1998;83-95.
72. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69-72.
73. Zechel M.A., Krawetz M., Singh B. Epitope dominance: Evidence for reciprocal determinant spreading to glutamic acid decarboxylase (GAD) in NOD mice. Immunol. Rev. 164:1998;111-118.
74. Karounos D.G., Wolinsky J.S., Thomas J.W. Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J. Immunol. 150:1993;3080-3085.
75. Atkinson M.A., Bowman M.A., Campbell L., Darrow B., Kaufmann D.L., Maclaren N.K. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes mellitus. J. Clin. Invest. 94:1994;2125-2129.
76. Tian J., Lehmann P.V., Kaufmann D.L. T cell reactivity between Coxsackie virus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med. 180:1994;1979-1984.
77. Benoist C., Mathis D. Autoimmunity. The pathogen connection. Nature. 394:1998;227-228.
78. Abbas A.K., Sher A., Murphy K.M. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
79. Shevach E. Microbial products induce autoimmunedisease by an IL-12-dependent pathway. J. Immunol. 158:1997;5087-5090.
80. Chaturvedi P., Yu Q., Southwood S., Sette A., Singh B. Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells. Int. Immunol. 8:1996;745-755.
81. Pakala S.V., Kurrer M.O., Katz J.D. T Helper 2 (Th2) T Cells Induce Acute Pancreatitis and Diabetes in Immune-compromised Nonobese Diabetic (NOD) Mice. J. Exp. Med. 186:1997;299-306.
82. Singh B. Possible immunological treatment for Type I diabetes in the 21st century. Practical Diabetes International. 14:1997;197-200.
83. Ma S.W., Zhao D.L., Yin Z.Q., Mukherjee R., Singh B., Qin H.Y., Stiller C.R., Jevnikar A.M. Transgenic plants expressing autoantigens fed to mice to induce oral tolerance. Nature Med. 3:1997;793-796.
84. Daniel D., Wegmann D.W. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous adminstration on insulin peptide B-(9-23). Proc Natl. Acad. Sci. U S A. 93:1996;956-960.
85. Zhang Z.J., Davidson L., Eisenbarth G., Weiner H.L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. U S A. 88:1991;10252-10256.